Article info
Systemic lupus erythematosus
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse
- Correspondence to Dr Alexis Mathian, Internal Medicine, Pitié-Salpêtrière Hospital, Paris 75013, France; alexis.mathian{at}aphp.fr
Citation
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse
Publication history
- Received April 18, 2019
- Revised September 3, 2019
- Accepted September 4, 2019
- First published September 30, 2019.
Online issue publication
May 12, 2021
Article Versions
- You are viewing the most recent version of this article.
- Previous version (12 May 2021).
- latest version (13 May 2021).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.